不依赖种族的2021 CKD-EPI方程在不列颠哥伦比亚省肾病患者管理中的实施影响
该研究基于加拿大不列颠哥伦比亚省PROMIS登记中11,604例非透析依赖的CKD患者,比较2021与2009 CKD-EPI方程估算的eGFR差异及eGFR类别重新分类情况。结果显示2021方程eGFR平均高2.7 ml/min/1.73 m²,约17%患者被重新分类到更高eGFR类别,且重新分类者2年内进展至肾衰竭的风险较未重新分类者低22%(调整HR 0.78,95%CI 0.65-0.94)。
要点
- 2021 CKD-EPI方程较2009方程eGFR平均升高2.7 ml/min/1.73 m²
- 约17%患者被重新分类至更高eGFR类别,其中28%从G5转为G4
- 重新分类者2年内进展至肾衰竭风险降低22%(调整HR 0.78,95%CI 0.65-0.94)
核心结论
- 2021 CKD-EPI方程较2009方程提供更高的eGFR值,且这种升高与后续真实世界CKD进展结局一致。
研究设计与样本
- 回顾性队列研究,纳入2016年3月31日在PROMIS登记、年龄≥19岁的非透析依赖CKD患者,共11,604例,中位年龄73岁,52%为男性。
主要发现
- 2021方程eGFR较2009方程平均高2.7 ml/min/1.73 m²,男性中变异更大。
- 约17%的患者被重新分类至更高eGFR类别,其中28%从G5转为G4。
- 重新分类者较未重新分类者进展至肾衰竭的风险低22%,调整子分布风险比(HR)为0.78(95%CI 0.65-0.94)。
关键数值与推荐
- eGFR差异:2021方程较2009方程平均高2.7 ml/min/1.73 m²。
- 重新分类比例:约17%患者被重新分类至更高eGFR类别。
- 肾衰竭风险:重新分类者调整HR为0.78(95%CI 0.65-0.94)。
临床怎么用
- 临床采用2021 CKD-EPI方程可能提高eGFR读数,需关注由此导致的eGFR类别上移及对诊断和长期管理的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: We investigated the implications of implementing race-free Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) 2021 equation among real-world patients with chronic kidney disease (CKD) from British Columbia (BC), Canada. METHODS: This study included nondialysis-dependent patients with CKD aged ≥19 years who were registered in the Patient Records and Outcome Management Information System (PROMIS) as of March 31, 2016 (index date) with ≥1 serum creatinine measurement within 1 year before the index date. Patients with a history of kidney transplantation before the index date were excluded. CKD-EPI 2021 versus 2009 equation was the exposure variable. Difference in mean estimated glomerular filtration rate (eGFR) and number (%) of patients reclassified to a different eGFR category were estimated. We used Fine and Gray subdistribution hazard model to investigate the association between change in eGFR category and progression to kidney failure (incident maintenance dialysis or kidney transplantation) within 2 years. RESULTS: A total of 11,604 patients (median age 73 years, 52% male) were included. Compared to the 2009 equation, eGFR from 2021 equation was on average 2.7 ml/min per 1.73 m2 higher. Variation was higher among males. Overall, ∼17% of the study sample were reclassified to a category with higher eGFR by 2021 equation (switchers). The highest proportion (28%) of patients were reclassified from G5 to G4. The risk of progressing to kidney failure was 22% less among switchers compared to nonswitchers; adjusted subdistribution hazard ratio (HR) (95% confidence interval [CI]) is 0.78 (0.65, 0.94). CONCLUSION: CKD-EPI 2021 equation appeared to provide higher eGFR compared to 2009 equation. This higher eGFR values appeared to be concordant with subsequent real-world CKD progression outcomes. Higher eGFR from the 2021 equation may have substantial clinical implications in both diagnosis as well as long-term care of patients with CKD.
引用
- Atiquzzaman M, Er L, Djurdjev O, et al. Implications of Implementing the 2021 CKD-EPI Equation Without Race on Managing Patients With Kidney Disease in British Columbia, Canada. Kidney Int Rep. 2024. PMID: 38765563. doi:10.1016/j.ekir.2024.01.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。